| FDP(s) | 1) Fibrinolytic split Products(= FSP) 2) Fibrinogen Degradation Products |
|---|---|
| FSP | familial spastic paraplegia; fibrin split products; fibrinogen split products; fine suspended partic... |
| MBL | Marine Biological Laboratory; menstrual blood loss; minimum bactericidal level |
| MOF | marine oxidation/fermentation; methotrexate, Oncovin, and fluorouracil; multiple organ failure |
| MPC | marine protein concentrate; maximum permissible concentration; mean plasma concentration; meperidine... |
| AGE | Advanced Glycation End Products |
|---|---|
| AGE | Advanced Glycosylated End-products |
| CPMP | Committee for Proprietary Medicinal Products |
| DPC | Diagnostic Products Corporation |
| DBP | Disinfection by-products |
| marine | 1. Of or pertaining to the sea; having to do with the ocean, or with navigation or naval affairs; nautical; as, marine productions or bodies; marine shells; a marine engine. 2. <geology> Formed by the action of the currents or waves of the sea; as, marine deposits. <medicine> Marine acid, a steam engine for propelling a vessel. Marine glue. See Glue. Marine insurance, insurance against the perils of the sea, including also risks of fire, piracy, and barratry. Marine interest, interest at any rate agreed on for money lent upon respondentia and bottomry bonds. Marine law. See Law. Marine league, three geographical miles. Marine metal, an alloy of lead, antimony, and mercury, made for sheathing ships. Marine soap, cocoanut oil soap; so called because, being quite soluble in salt water, it is much used on shipboard. Marine store, a store where old canvas, ropes, etc, are bought and sold; a junk shop. Origin: L. Marinus, fr. Mare the sea: cf. F. Marin. See Mere a pool. Source: Websters Dictionary (01 Mar 1998) |
|---|---|
| marine soap | A soap made of palm or coconut oil for use with sea water in which it is soluble. Synonym: salt water soap. (05 Mar 2000) |
| marine toxins | Toxic or poisonous substances elaborated by marine flora or fauna. They include also specific, characterised poisons or toxins for which there is no more specific heading, like those from poisonous fishes. Clupeotoxin, pahutoxin, prymnesin, scombrotoxin go here. (12 Dec 1998) |
| fluvio-marine | <geology> Formed by the joint action of a river and the sea, as deposits at the mouths of rivers. Origin: L. Fluvius river + E. Marine. Source: Websters Dictionary (01 Mar 1998) |
| biological products | Complex pharmaceutical substances, preparations, or agents of organic origin, usually obtained by biological methods or assay, that depend for their action on the processes affecting immunity. They are used especially in diagnosis and treatment of disease (as vaccines or pollen extracts). Biological products are differentiated from biological factors in that the latter are compounds with biological or physiological activity made by living organisms. (12 Dec 1998) |
| blood products | Biopharmaceutical products purified from human blood, such as the blood clotting factor VIII used to treat haemophiliacs. (Recombinant factor VIII is also on the market.) The term also refers to biopharmaceuticals that act on blood or the cells that make blood. These products are often produced by the cells themselves, but in such tiny amounts that extracting them from blood is impractical, and so they are genetically engineered. (14 Nov 1997) |
| gene products, env | Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesised as protein precursors (polyproteins) and later cleaved into the final products by a viral protease. (12 Dec 1998) |
| gene products, gag | Proteins coded by the retroviral gag gene. The products are usually synthesised as protein precursors or polyproteins, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. Gag is short for group-specific antigen. (12 Dec 1998) |
| gene products, nef | Products of the HIV nef gene (formerly 3'-orf gene). The products trans-suppress viral replication and function as negative regulators of transcription. Nef stands for negative factor. (12 Dec 1998) |
| gene products, pol | Retroviral proteins coded by the pol gene. Often synthesised as a gag-pol fusion protein (fusion proteins, gag-pol) and later cleaved into final products that include reverse transcriptase, endonuclease/integrase, and viral protease. Pol is short for polymerase, the enzyme class of reverse transcriptase. (12 Dec 1998) |
| gene products, rev | Trans-acting nuclear proteins whose functional expression are required for HIV viral replication. Specifically, the rev gene products are required for processing and translation of the HIV gag and env mRNAs, and thus rev regulates the expression of the viral structural proteins. Rev can also regulate viral regulatory proteins. A cis-acting antirepression sequence (car) in env, also known as the rev-responsive element (rre), is responsive to the rev gene product. Rev is short for regulator of virion. (12 Dec 1998) |
| gene products, rex | Post-transcriptional regulatory proteins required for the accumulation of mRNAs that encode the gag and env gene products in HTLV-I and HTLV-II. The rex (regulator x; x is undefined) products act by binding to elements in the ltr. (12 Dec 1998) |
| gene products, tat | Trans-acting transcription factors. Nuclear proteins whose expression is required for HIV viral replication. The tat protein stimulates HIV-ltr-driven RNA synthesis for both viral regulatory and viral structural proteins. Tat stands for trans-activation of transcription. (12 Dec 1998) |
| gene products, tax | Transcriptional trans-acting proteins of the promoter elements found in the long-terminal repeats (ltr) of HTLV-I and HTLV-II. The tax (trans-activator x; x is undefined) proteins act by binding to enhancer elements in the ltr. (12 Dec 1998) |
| gene products, vif | A 23 kD regulatory protein important for virion infectivity in HIV. The protein is found in the cytoplasm of HIV-infected cells and is not absolutely required for virion formation. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|